Prognostic and predictive value of PD-L2 DNA methylation and mRNA expression in melanoma
2020 · Clinical Epigenetics · 40 citations
https://doi.org/10.1186/s13148-020-00883-9
C
Christian Posch
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
187
Papers
3.0K
Citations
28
h-index
55
i10-index
Christian Posch is an academic researcher from Sigmund Freud Privatuniversität Wien. The author has contributed to research in topics: Cutaneous Melanoma Detection and Management & Melanoma and MAPK Pathways & Cancer Immunotherapy and Biomarkers. The author has an h-index of 28, co-authored 159 publications.
ORCID: 0000-0003-0296-3567Papers by this author
worksThe lincRNA MIRAT binds to IQGAP1 and modulates the MAPK pathway in NRAS mutant melanoma
2018 · Scientific Reports · 34 citations
https://doi.org/10.1038/s41598-018-27643-3
CTLA4 promoter methylation predicts response and progression-free survival in stage IV melanoma treated with anti-CTLA-4 immunotherapy (ipilimumab)
2020 · Cancer Immunology Immunotherapy · 32 citations
https://doi.org/10.1007/s00262-020-02777-4
Real‐world outcomes using <scp>PD</scp>‐1 antibodies and <scp>BRAF</scp> + <scp>MEK</scp> inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland
2022 · Journal of the European Academy of Dermatology and Venereology · 27 citations
https://doi.org/10.1111/jdv.18779
Inflammatory Cues Direct Skin-Resident Type 1 Innate Lymphoid Cells to Adopt a Psoriasis-Promoting Identity
2023 · JID Innovations · 4 citations
https://doi.org/10.1016/j.xjidi.2023.100204
Outcomes after stereotactic radiosurgery of brain metastases in patients with malignant melanoma and validation of the melanoma molGPA
2021 · Clinical & Translational Oncology · 2 citations
https://doi.org/10.1007/s12094-021-02607-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat